PFE vs RL · P/E 20, rev $62.58B vs P/E 24, rev $8.11B
Pfizer Inc (PFE) versus Ralph Lauren Corp Class A (RL) — a side-by-side from cached financials, not a winner call.
Pfizer Inc (PFE) is a drug manufacturers - general company listed on NYSE. It is led by Albert Bourla.
Ralph Lauren Corp Class A (RL) is a apparel manufacturing company listed on US.
Latest reported PFE revenue for 2025-12-31 was $62.58B. Net income was $7.77B. Revenue was down 1.6% from 2024-12-31 to 2025-12-31. PFE currently screens at market cap $147.73B and trailing P/E 19.8.
Latest reported RL revenue for 2026-03-28 was $8.11B. Net income was $941.1M. Revenue was up 14.6% from 2025-03-29 to 2026-03-28. RL currently screens at market cap $16.95B and trailing P/E 24.1.
PFE currently screens at market cap $147.73B and trailing P/E 19.8. RL currently screens at market cap $16.95B and trailing P/E 24.1.
Not investment advice. Open the PFE and RL stock pages for the full models.
Not investment advice.